Kedudukan dalam Saham
#42756
Midatech Pharma plc operates as a pharmaceutical company specializing in drug... Midatech Pharma plc operates as a pharmaceutical company specializing in drug delivery technologies. Its core activities revolve around the research and development of therapeutic compounds, with operations spanning the United Kingdom, broader Europe, and global markets. Currently, its pipeline includes several key developments: MTX110, an innovative direct-delivery therapy targeting diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immunosuppressant designed for topical use against psoriasis; MTD211, a sustained-release version of brexpiprazole intended for managing schizophrenia and as an add-on therapy for major depressive disorder; and MTD219, a prolonged-action formulation of tacrolimus aimed at reducing the likelihood of organ transplant rejection. Beyond its specific drug candidates, Midatech Pharma provides advanced drug delivery platforms. These include Q-Sphera, a microtechnology based on polymer microspheres that enables drugs to be released over extended periods; MidaSolve, a nanotechnology employing oligosaccharides to enhance drug solubility, allowing direct and localized administration into tumors; and MidaCore, a gold nanoparticle system engineered to precisely deliver chemotherapeutic or immunotherapeutic agents to disease sites. Established in 2000, the company maintains its headquarters in Cardiff, United Kingdom.
Harga Saham
$0.05309195
Disegerakkan terakhir: 2023-04-24
Perubahan (1 tahun)
0.00%
Perdagangan Midatech Pharma plc (MTPH)
Pendapatan untuk Midatech Pharma plc (MTPH)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Midatech Pharma plc, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Midatech Pharma plc dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun |
Pendapatan |
Ubah |
|
Tidak cukup data untuk tarikh yang disediakan. |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat |
Pendapatan |
Perbezaan Pendapatan |
Negara |
|
|
$5.27B |
-
|
US
|
|
|
$1.95B |
-
|
NL
|
|
|
- |
-
|
CH
|
|
|
$3.01B |
-
|
BE
|
|
|
- |
-
|
KR
|
